Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Benjamin Fangman

2PUBLICATIONS

18CO-AUTHORS

Haematological tumoursPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 10, 2024

Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.

Athira Jayan, Jasmine S Sukumar, Benjamin Fangman

|Jan 11, 2021

Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.

Benjamin D Fangman, Suleyman Y Goksu, Nivan Chowattukunnel

Pageof 1

Frequent Collaborators

1 joint publications

Suleyman Y Goksu

1 joint publications

Muhammad S Beg

1 joint publications

Nina N Sanford

1 joint publications

Aravind Sanjeevaiah

1 joint publications

John Cox

1 joint publications

Michael R Folkert

1 joint publications

Todd A Aguilera

1 joint publications

Syed M Kazmi

1 joint publications

Athira Jayan

1 joint publications

Jasmine S Sukumar

Frequent Collaborators

1 joint publications

Suleyman Y Goksu

1 joint publications

Muhammad S Beg

1 joint publications

Nina N Sanford

1 joint publications

Aravind Sanjeevaiah

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

See more related videos